Drug resistance patterns in HIV-1 isolates from patients receiving prolonged AZT/3TC combination therapy

被引：0
|
作者：
Bloor, S
机构：
[1] UNIV FRANKFURT KLINIKUM,D-6000 FRANKFURT,GERMANY
[2] TIBOTEC,ANTWERP,BELGIUM
[3] GLAXO WELLCOME,STEVENAGE,HERTS,ENGLAND
[4] UNIV PITTSBURGH,PITTSBURGH,PA
来源：
AIDS | 1996年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：P2 / P2
页数：1
相关论文
共 50 条
  • [1] The rise in HIV-1 RNA load during 3TC/AZT combination therapy is associated with the selection of viruses resistant to both 3TC and AZT
    Nijhuis, M
    deJong, D
    vanLeeuwen, R
    deGroot, T
    Keulen, W
    Schuurman, R
    Boucher, C
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 52 - 52
  • [2] DEVELOPMENT OF 3TC-RESISTANT HIV-1 IN PATIENTS RECEIVING 3TC
    KAVLICK, MF
    KOJIMA, E
    SHIRASAKA, T
    PLUDA, J
    YARCHOAN, R
    MITSUYA, H
    CLINICAL RESEARCH, 1994, 42 (02): : A280 - A280
  • [3] A randomized, open-label, comparative trial of AZT/3TC versus AZT/3TC/ddI in antiretroviral naive HIV-1 infected Thai patients.
    Ungsedhapand, C
    Kroon, EDMB
    Suwannagool, S
    Ruxrungtham, K
    Newell, M
    Yinsuan, N
    Sonjai, A
    Ubolyam, S
    Weverling, GW
    Buranapraditkun, S
    Tiengrim, S
    Sirivichayakul, S
    Kunanusont, C
    Lange, JMA
    Cooper, DA
    Phanuphak, P
    AIDS, 1998, 12 : S96 - S96
  • [4] Acquisition of genotypic resistance in drug-naive patients receiving 3TC/ZVD combination therapy or ZDV monotherapy
    Loveday, C
    Kaye, S
    Comber, E
    Collis, P
    Tedder, RS
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1995, 10 : 58 - 58
  • [5] Genotypic characterization of an HIV-1 mutant co-resistant to AZT and 3TC
    Kemp, SD
    Kohli, A
    Larder, BA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 51 - 51
  • [6] The effects of RNase H inhibitors and nevirapine on the susceptibility of HIV-1 to AZT and 3TC
    Davis, Caroline A.
    Parniak, Michael A.
    Hughes, Stephen H.
    VIROLOGY, 2011, 419 (02) : 64 - 71
  • [7] Virological response to AZT/3TC combination therapy in AZT-naive patients (trial NUCB 3001)
    Harrigan, PR
    Kinghorn, I
    Kohli, A
    Kemp, SD
    Bloor, S
    Larder, BA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 56 - 56
  • [8] Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination
    Chan, Sherine S. L.
    Santos, Janine H.
    Meyer, Joel N.
    Mandavilli, Bhaskar S.
    Cook, Dennis L., Jr.
    McCash, Consuelo L.
    Kissling, Grace E.
    Nyska, Abraham
    Foley, Julie F.
    van Houten, Bennett
    Copeland, William C.
    Walker, Vernon E.
    Witt, Kristine L.
    Bishop, Jack B.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2007, 48 (3-4) : 190 - 200
  • [9] Acquisition of genotypic drug resistance in zidovudine (ZDV)-experienced patients receiving 3TC/ZDV combination therapy or ZDV monotherapy
    Kaye, S
    Loveday, C
    Comber, E
    Collis, P
    Tedder, RS
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1995, 10 : 57 - 57
  • [10] Therapy with 3TC and AZT in nucleoside analogues experienced patients with advanced HIV-infection
    Low, P
    Kraetsch, HG
    Rascu, A
    Grunke, M
    Kalden, JR
    Harrer, T
    AIDS, 1996, 10 : P50 - P50
12345